Sichuan Kelun Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Sichuan Kelun Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Sichuan Kelun Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Interest receivable94,050,8360.00439342015-06-30historic
Other current liabilities2,581,664,2390.1204342015-06-30historic
Purchases of fixed assets and others1,114,369,6230.05197722015-06-30historic
Notes receivable1,186,789,7200.055351042015-06-30historic
Interests payable123,759,4870.005771112015-06-30historic
Long term accounts payable440,000,0000.020521162015-06-30historic
Selling expenses475,971,1940.02221582015-06-30historic
Construction materials4,912,4502.3E-41692015-06-30historic
Cash paid for other financing activities242,539,1440.011311762015-06-30historic
Total non-current assets13,127,898,5890.612261912015-06-30historic
Cash paid for taxes502,549,6420.023442132015-06-30historic
Cash paid for other investing activities40,000,0000.001872212015-06-30historic
Cash from minority shareholders of subsidiaries300,0001.0E-52272015-06-30historic
Fixed assets5,985,751,0310.279172292015-06-30historic
Capital reserve4,429,904,9220.20662342015-06-30historic
Intangible assets982,955,2570.045842422015-06-30historic
Net income405,198,6540.01892482015-06-30historic
Total profit478,640,8570.022322652015-06-30historic
Operating profit443,574,4500.020692682015-06-30historic
Long term borrowings1,096,215,1430.051132722015-06-30historic
Other current assets573,738,1180.026762792015-06-30historic
Financial expenses140,380,0020.006552812015-06-30historic
Goodwill157,080,3490.007332922015-06-30historic
Total liabilities and equity21,570,689,2731.006023022015-06-30historic
Investment income from associate and joint venture935,3274.0E-53202015-06-30historic
Non-operating loss5,361,8502.5E-43322015-06-30historic
Total liabilities10,328,120,5740.481693372015-06-30historic
Disposal of fixed assets and others1,563,3897.0E-53522015-06-30historic
Deferred tax assets102,550,5180.004783542015-06-30historic
Accounts payable1,558,796,9940.07273582015-06-30historic
Short term borrowings2,044,000,0000.095333652015-06-30historic
Total comprehensive income319,660,3150.014913722015-06-30historic
Cash from other investing activities6,068,0002.8E-43942015-06-30historic
Inventories1,977,530,1350.092234152015-06-30historic
Cash paid for dividends, profits or interests229,249,9160.010694292015-06-30historic
Cash inflows from operating activities4,249,372,6650.198184342015-06-30historic
Revenue3,835,606,9190.178894412015-06-30historic
Total cost of goods sold3,412,491,5850.159154572015-06-30historic
Cash inflows from financing activities2,123,831,0210.099054752015-06-30historic
Cash outflows from operating activities3,597,305,5550.167774862015-06-30historic
Prepayment258,521,9030.012064972015-06-30historic
Net cashflow from financing activities305,457,9970.014255092015-06-30historic
Other receivables123,238,2580.005755552015-06-30historic
Minority interest163,749,8850.007645572015-06-30historic
Net cash and cash equivalents ending balance1,431,743,0250.066775572015-06-30historic
Long term equity investment48,164,9670.002256542015-06-30historic
Other payables154,144,0380.007196952015-06-30historic
Payroll payable30,856,2470.001448122015-06-30historic
Net change in cash-170,112,177-0.007938762015-06-30historic
Minority interests gain-4,053,520-1.9E-48922015-06-30historic
Comprehensive income attributable to minority shareholders-4,892,688-2.3E-49002015-06-30historic
Diluted eps10.010832015-06-30historic
Net cash flows from investing activities-1,127,026,359-0.0525611842015-06-30historic